Penserra Capital Management LLC Closed Holding Positions

Penserra Capital Management LLC

  • $4.61 Billion
  • Q3 2024
Stock Closed Quarter Shares Sold Price Range Trade History
MDGL
Madrigal Pharmaceuticals, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
380
$72.34 - $95.09 $27.5K - $36.1K
Marinus Pharmaceuticals Inc
Q4 2021 Filed on Feb 15, 2022
835
N/A
MNOV
Medicinova Inc

Healthcare
Q4 2021 Filed on Feb 15, 2022
1,120
$2.61 - $4.42 $2.92K - $4.95K
MRSN
Mersana Therapeutics, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
1,640
$5.48 - $9.86 $8.99K - $16.2K
NLTX
Neoleukin Therapeutics, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
970
$4.65 - $7.75 $4.51K - $7.52K
NXTC
Next Cure, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
630
$5.7 - $9.1 $3.59K - $5.73K
NKTX
Nkarta, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
755
$12.79 - $26.88 $9.66K - $20.3K
NRIX
Nurix Therapeutics, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
1,015
$26.43 - $34.5 $26.8K - $35K
OCUL
Ocular Therapeutix, Inc

Healthcare
Q4 2021 Filed on Feb 15, 2022
1,750
$6.16 - $12.07 $10.8K - $21.1K
Odonate Therapeutics Inc
Q4 2021 Filed on Feb 15, 2022
880
N/A
ORIC
Oric Pharmaceuticals, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
900
$12.01 - $20.3 $10.8K - $18.3K
OVID
Ovid Therapeutics Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
1,555
$3.13 - $3.73 $4.87K - $5.8K
PRTK
Paratek Pharmaceuticals, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
1,110
$4.07 - $5.3 $4.52K - $5.88K
PASG
Passage Bio, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
1,235
$6.24 - $10.2 $7.71K - $12.6K
PLRX
Pliant Therapeutics, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
820
$12.27 - $18.26 $10.1K - $15K
PRVB
Provention Bio, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
1,450
$5.59 - $7.39 $8.11K - $10.7K
RETA
Reata Pharmaceuticals Inc

Healthcare
Q4 2021 Filed on Feb 15, 2022
720
$25.61 - $110.96 $18.4K - $79.9K
RDHL
Red Hill Biopharma Ltd.

Healthcare
Q4 2021 Filed on Feb 15, 2022
1,065
$2.31 - $5.85 $2.46K - $6.23K
RLAY
Relay Therapeutics, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
2,115
$26.0 - $37.03 $55K - $78.3K
RLMD
Relmada Therapeutics, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
400
$16.93 - $26.82 $6.77K - $10.7K
RPTX
Repare Therapeutics Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
850
$19.66 - $28.11 $16.7K - $23.9K
REPL
Replimune Group, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
1,070
$25.43 - $34.25 $27.2K - $36.6K
RVMD
Revolution Medicines, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
1,690
$24.35 - $33.7 $41.2K - $57K
SAGE
Sage Therapeutics, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
1,345
$37.06 - $47.11 $49.8K - $63.4K
SELB
Selecta Biosciences Inc

Healthcare
Q4 2021 Filed on Feb 15, 2022
2,630
$2.89 - $4.43 $7.6K - $11.7K
SPRO
Spero Therapeutics, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
730
$13.09 - $18.77 $9.56K - $13.7K
SWTX
Spring Works Therapeutics, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
1,130
$53.3 - $75.84 $60.2K - $85.7K
SMMT
Summit Therapeutics Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
2,225
$2.45 - $5.64 $5.45K - $12.5K
SURF
Surface Oncology, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
1,040
$4.73 - $7.9 $4.92K - $8.22K
STRO
Sutro Biopharma, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
1,055
$14.25 - $23.53 $15K - $24.8K
SNDX
Syndax Pharmaceuticals Inc

Healthcare
Q4 2021 Filed on Feb 15, 2022
1,115
$15.23 - $22.47 $17K - $25.1K
TCRR
Tcr2 Therapeutics Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
875
$4.58 - $8.34 $4.01K - $7.3K
TVTX
Travere Therapeutics, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
1,390
$24.34 - $31.17 $33.8K - $43.3K
PCVX
Vaxcyte, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
1,195
$19.32 - $26.45 $23.1K - $31.6K
VSTM
Verastem, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
4,130
$2.05 - $3.2 $8.47K - $13.2K
VIR
Vir Biotechnology, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
2,990
$30.97 - $54.03 $92.6K - $162K
XENE
Xenon Pharmaceuticals Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
940
$15.6 - $35.4 $14.7K - $33.3K
ZNTL
Zentalis Pharmaceuticals, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
1,030
$66.92 - $84.79 $68.9K - $87.3K
TCRT
Alaunos Therapeutics, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
4,935
$1.09 - $1.89 $5.38K - $9.33K
AAN
Aaron'S Company, Inc.

Industrials
Q4 2021 Filed on Feb 15, 2022
16,283
$21.89 - $31.04 $356K - $505K
Altimeter Growth Corp
Q4 2021 Filed on Feb 15, 2022
11,414
N/A
Broadstone Acquisition Corp
Q4 2021 Filed on Feb 15, 2022
5,086
N/A
Horizon Acquisition Corp
Q4 2021 Filed on Feb 15, 2022
6,995
N/A
Yucaipa Acquisition Corp
Q4 2021 Filed on Feb 15, 2022
7,167
N/A
Bowx Acquisition Corp
Q4 2021 Filed on Feb 15, 2022
10,281
N/A
IBRX
Immunity Bio, Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
8,950
$5.67 - $10.18 $50.7K - $91.1K
VYNE
Vyne Therapeutics Inc.

Healthcare
Q4 2021 Filed on Feb 15, 2022
1,185
$0.91 - $1.5 $1.08K - $1.78K
17 Ed & Technology Group Inc
Q4 2021 Filed on Feb 15, 2022
130,205
N/A
DAO
Youdao, Inc.

Consumer Defensive
Q4 2021 Filed on Feb 15, 2022
16,625
$10.0 - $17.68 $166K - $294K
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email